NCT04637607 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Carrillo AE, Christodoulou VX, Koutedakis Y, Flouris AD
Autonomic nervous system modulation during an archery competition in novice and experienced adolescent archers. J Sports Sci. 2011 Jun;29(9):913-7. doi: 10.1080/02640414.2011.568514.
Hatfield BD, Landers DM, Ray WJ
Cardiovascular-CNS interactions during a self-paced, intentional attentive state: elite marksmanship performance. Psychophysiology. 1987 Sep;24(5):542-9.

Immediate Effect of Non-invasive Auricular Acupoint Stimulation on the Performance and Meridian Activities of Archery Athletes- a Protocol for Randomized Controlled Trial

Details for clinical trial NCT04637607

Clinical trial NCT04637607 - References